Bulletin
Investor Alert

London Markets Open in:

NeuBase Therapeutics Inc.

NAS: NBSE

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Nov 29, 2021, 5:31 p.m.

/zigman2/quotes/206101919/composite

$

3.02

Change

-0.09 -2.89%

Volume

Volume 241

Quotes are delayed by 20 min

/zigman2/quotes/206101919/composite

Previous close

$ 3.10

$ 3.11

Change

+0.01 +0.32%

Day low

Day high

$3.01

$3.19

Open

52 week low

52 week high

$3.01

$12.89

Open

William R. Mann

Founder of Lodestar Biopharma Solutions LLC, William R. Mann presently is Chief Operating Officer for NeuBase Therapeutics, Inc.

He previously held the position of President & Director at Helsinn Therapeutics (U.S.), Inc., Principal at Novartis Corp. and Vice President-Corporate Development of Sapphire Therapeutics, Inc.

He received a doctorate from the University of Aberdeen and an MBA from Rutgers State University of New Jersey.

Transactions

Date Shares Transaction Value
04/26/2021 5,000   Acquisition at $5 per share. 25,000

Officers and Executives

Dr. Dietrich A. Stephan
Chairman, President, CEO & Chief Financial Officer
Dr. William R. Mann
Chief Operating Officer
Mr. Robert Friedlander
Chief Medical Officer
Dr. Curt W. Bradshaw
Chief Scientific Officer
Dr. Sandra Porcile Rojas-Caro
Chief Medical Officer
Dr. Anthony Rossomando
Chief Technology Officer
Ms. Shannon McCarthy
Chief People Officer
Dr. Dov A. Goldstein
Independent Director
Dr. Franklyn G. Prendergast
Independent Director
Mr. Eric I. Richman
Independent Director
Mr. Gerald J. McDougall
Independent Director
Link to MarketWatch's Slice.